These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22767378)

  • 21. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of desorption kinetics from albumin on hepatic extraction efficiency and hepatic clearance: a model study.
    Krause S; Goss KU
    Arch Toxicol; 2018 Jul; 92(7):2175-2182. PubMed ID: 29796692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A streamlined method to predict hepatic clearance using human liver microsomes in the presence of human plasma.
    Skaggs SM; Foti RS; Fisher MB
    J Pharmacol Toxicol Methods; 2006; 53(3):284-90. PubMed ID: 16300971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
    Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
    Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance.
    Fagerholm U
    Xenobiotica; 2009 Jan; 39(1):57-71. PubMed ID: 19219748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the influence of protein binding on pharmacological activity of drugs.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model.
    Hsu SH; Cheng AC; Chang TY; Pao LH; Hsiong CH; Wang HJ
    Biomed Pharmacother; 2021 Sep; 141():111855. PubMed ID: 34229248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein binding and drug clearance.
    Rowland M
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():10-7. PubMed ID: 6705422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
    Poulin P; Kenny JR; Hop CE; Haddad S
    J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
    Chow FS; Piekoszewski W; Jusko WJ
    Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deriving an explicit hepatic clearance equation accounting for plasma protein binding and hepatocellular uptake.
    Yoon M; Clewell HJ; Andersen ME
    Toxicol In Vitro; 2013 Feb; 27(1):11-5. PubMed ID: 23085432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fixation of drugs on plasma proteins].
    Tillement JP; Houin G; Zini R; Urien S; Albengres E; Barré J; Sébille B
    Sem Hop; 1983 May; 59(18):1413-22. PubMed ID: 6306828
    [No Abstract]   [Full Text] [Related]  

  • 39. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes.
    Kwon Y; Morris ME
    Pharm Res; 1997 Jun; 14(6):780-5. PubMed ID: 9210197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.